Medication adherence has shifted in the last decade. The early interventions were single-point fixes: a reminder text, a generic pillbox, a refill alert. They worked a little. The newer wave treats adherence as a system, with packaging, digital tools, and clinical follow-up working together. The results are measurably better.
Why single interventions plateau
A reminder text by itself lifts adherence in trials by maybe 5-10%. A calendar wallet by itself lifts it by 30%. A reminder text combined with a calendar wallet and a nurse follow-up lifts it by 50%+. The interventions are not additive in a simple way; they reinforce each other.
Single-point interventions plateau because patients are different. Some forget, some don't understand the regimen, some experience side effects they don't report. A multi-channel system catches the case that any single intervention misses.
The five layers of a modern adherence system
1. Pack design
Calendar wallets, color-coded titration, senior-friendly opening. The pack is the only daily touchpoint the patient has with the medication. Get this right and the rest gets easier.
2. Smart pack integration
NFC tags or 2D codes linked to an app. The patient scans the pack, the app logs the dose. Adherence data flows back to the healthcare provider, the trial sponsor, or both.
3. Patient app
Daily reminders, side-effect logging, refill prompts, educational content. The app is most effective when it integrates with the pack scanning, less effective standalone.
4. Clinical follow-up
Nurse calls, pharmacist consultations, telehealth check-ins. Triggered when the app shows a missed week or a side-effect report.
5. Family or caregiver involvement
Especially for elderly patients on multi-drug regimens. The pack design carries instructions a caregiver can follow when the patient can't.
What's actually new in 2026
Three areas where the technology genuinely shifted in the last two years:
Connected packs at lower cost. NFC-enabled wallets used to add 50 cents per pack. They're now closer to 5 cents at volume, which makes them feasible outside specialty therapy.
AI-driven adherence prediction. The app stops sending generic reminders and starts sending the right reminder for this patient based on their pattern. Early data suggests another 10-15% lift over generic reminders.
Real-world adherence data feeding into pricing. Several EU payers now factor adherence performance into pricing negotiations for high-cost specialty therapies. That makes adherence a P&L item, not a CSR item.
Where to start
If you're launching a chronic medication and adherence is going to matter for outcomes, the order to implement is roughly: pack design first (highest impact, lowest cost), then smart pack integration if the therapy justifies it, then app, then clinical follow-up. Don't try to launch all five at once.
We design cold seal wallets with adherence in mind from the brief, including NFC integration where the therapy budget supports it. Send us the patient profile and treatment regimen and we'll come back with a wallet concept that fits.
Request a free sample now!
